What is the most recent earnings date for CYCC stock?
CYCLACEL PHARMACEUTICALS INC (CYCC) last reported earnings on 8/12/2025.
CYCLACEL PHARMACEUTICALS INC (CYCC) Earnings History & Surprises
NASDAQ:CYCC • US23254L8019
Current stock price
6.365 USD
-0.4 (-5.98%)
At close:
6.4 USD
+0.04 (+0.55%)
After Hours:
CYCC Earnings overview
Past quarterly earnings results for CYCLACEL PHARMACEUTICALS INC (CYCC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Nov 10, 2025
- Period
- Q3 / 2025
- EPS Estimate
- -$0.31
- Revenue Estimate
- 25.5K
Last Reported
Most Recent- Release Date
- Aug 12, 2025
- Period
- Q2 / 2025
- EPS Reported
- EPS Surprise
- %
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.31 | - | 99.82% | 25.5K | -100.00% | -100.00% | ||
| Q1 2025 | -0.30 | - | 99.19% | 25.5K | -100.00% | -100.00% | ||
| Q4 2024 | -0.30 | - | 99.70% | 10.2K | -100.00% | -100.00% | ||
| Q3 2024 | -43.20 | -135.86 | 68.20% | 63.27% | 10K | 5.1K | 96.08% | -37.50% |
| Q2 2024 | -172.80 | -351.29 | 50.81% | -63.64% | 4K | 30.6K | -86.93% | -98.93% |
| Q1 2024 | -36.32 | -77.44 | 53.10% | 67.80% | 29K | - | - | |
| Q4 2023 | -99.68 | -96.18 | -3.64% | 30.78% | 31K | - | - | |
| Q3 2023 | -117.60 | -88.94 | -32.22% | -16.67% | 16K | - | - | |
| Q2 2023 | -105.60 | -123.22 | 14.30% | 4.35% | 373K | - | - | |
| Q1 2023 | -112.80 | -162.38 | 30.53% | -11.90% | - | - | ||
| Q4 2022 | -144.00 | -118.12 | -21.91% | -11.11% | - | - | ||
| Q3 2022 | -100.80 | -137.90 | 26.91% | 22.22% | - | - | ||
| Q2 2022 | -110.40 | -153.06 | 27.87% | 17.86% | - | - | ||
| Q1 2022 | -100.80 | -167.50 | 39.82% | 16.00% | - | - | ||
| Q4 2021 | -129.60 | -159.94 | 18.97% | 59.70% | - | - | ||
| Q3 2021 | -129.60 | -159.12 | 18.55% | -14.89% | - | - | ||
| Q2 2021 | -134.40 | -121.58 | -10.54% | 3.45% | - | - | ||
| Q1 2021 | -120.00 | -119.14 | -0.72% | 66.22% | - | - | ||
| Q4 2020 | -321.60 | -126.07 | -155.09% | - | - | - | ||
| Q3 2020 | -112.80 | -134.64 | 16.22% | - | - | - | ||
| Q2 2020 | -139.20 | -114.24 | -21.85% | - | - | - | ||
| Q1 2020 | -355.20 | -709.92 | 49.97% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-50.98%
Max Revenue beat (4)
96.08%
Min Revenue beat (4)
-100.00%
Analysis
CYCC has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CYCC reported -51.0% below the revenue estimates on average.
Related analysis
CYCLACEL PHARMACEUTICALS INC / CYCC Earnings FAQ
Can you provide information on whether CYCLACEL PHARMACEUTICALS INC beat earnings estimates in the last quarter?
CYCLACEL PHARMACEUTICALS INC (CYCC) missed EPS estimates and missed revenue estimates in the most recent quarter.